12/3/2024

Janusmed fosterpåverkan

Janusmed fosterpåverkan – VALONTAN

Janusmed fosterpåverkan tillhandahåller bedömningar av eventuella risker för fostret, när en gravid kvinna använder olika läkemedel. Observera att texterna är generella, och att en bedömning måste göras i varje enskilt fall. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed fosterpåverkan och för att göra sökningar klicka här.

Tillbaka till index
2 2
2 2

Dimenhydrinat

Dimenhydrinat

Klass : 2

  1. Schaefer C, Peters P, Miller RK. Drugs During Pregnancy and Lactation: Treatment Options and Risk Assessment. Academic Press, Elsevier; 2015.
  2. Czeizel AE, Vargha P. A case-control study of congenital abnormality and dimenhydrinate usage during pregnancy. Arch Gynecol Obstet. 2005;271(2):113-8.
  3. Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy. Publishing Sciences Group, Littleton, Mass. 1977.
  4. Etwel F, Faught LH, Rieder MJ, Koren G. The Risk of Adverse Pregnancy Outcome After First Trimester Exposure to H1 Antihistamines: A Systematic Review and Meta-Analysis. Drug Saf. 2017;40(2):121-132.
  5. Gilboa SM, Strickland MJ, Olshan AF, Werler MM, Correa A, National Birth Defects Prevention Study. Use of antihistamine medications during early pregnancy and isolated major malformations. Birth Defects Res A Clin Mol Teratol. 2009;85(2):137-50.
  6. Mazzotta P, Magee LA. A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy. Drugs 2000;59:781-800.
  7. Puhó EH, Szunyogh M, Métneki J, Czeizel AE. Drug treatment during pregnancy and isolated orofacial clefts in hungary. Cleft Palate Craniofac J 2007;44:194-202.
  8. Hansen C, Desrosiers TA, Wisniewski K, Strickland MJ, Werler MM, Gilboa SM. Use of antihistamine medications during early pregnancy and selected birth defects: The National Birth Defects Prevention Study, 1997-2011. Birth Defects Res. 2020;112(16):1234-1252.
  9. Parkin DE. Probable Benadryl withdrawal manifestations in a newborn infant. J Pediatr. 1974;85(4):580.
  10. Miller AA. Diphenhydramine toxicity in a newborn: a case report. J Perinatol. 2000;20(6):390-1.
  11. WATT LO. Oxytocic effects of dimenhydrinate in obstetrics. Can Med Assoc J. 1961;84(10):533-4.
  12. ROTTER CW, WHITAKER JL, YARED J. The use of intravenous dramamine to shorten the time of labor and potentiate analgesia. Am J Obstet Gynecol. 1958;75(5):1101-4.
  13. Hay TB, Wood C. The effect of dimenhydrinate on uterine contractions. Aust N Z J Obstet Gynaecol. 1967;7(2):81-9.
  14. Shephard B, Cruz A, Spellacy W. The acute effects of Dramamine on uterine contractability during labor. J Reprod Med. 1976;16(1):27-8.
  15. Lemay M, Samaan M, St Michel P, Granger L, Pigeon R. [Immediate effects of dimenhydrinate on uterine contraction and the fetal cardiac rhythm during labor]. Can Med Assoc J. 1982;127(7):606-7.
  16. Abernathy A, Alsina L, Greer J, Egerman R. Transient Fetal Tachycardia After Intravenous Diphenhydramine Administration. Obstet Gynecol. 2017;130(2):374-376.
  17. Brost BC, Scardo JA, Newman RB. Diphenhydramine overdose during pregnancy: lessons from the past. Am J Obstet Gynecol. 1996;175(5):1376-7.
  18. Shenai N, Shulman J, Gopalan P, Cheng E, Cerimele JM. Fetal Outcomes in Intentional Over-the-Counter Medication Overdoses in Pregnancy. Psychosomatics. 2018;59(4):400-404.